Healthcare News - An Overview
Novo CEO pressed by Senate to chop costs of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the business would consider new talks with insurers in regards to the list selling prices of Wegovy and copyright when they pledge to maintain the medicines on their formularies.Listen to the posting 10 min This audio is c